论文部分内容阅读
目的：研究早孕及早期中孕引产行米非司酮、米索前列醇联合疗法的临床效果。方法：从我院2011年3月-2015年5月所接收孕妇中抽选早孕及早期中孕引产120例作为本次调查对象，分成不同疗法组，其中：对照组孕妇行常规吸宫术疗法，实验组孕妇行米非司酮、米索前列醇联合疗法，于临床预后评估效果。结果：实验组孕妇临床流产效果81.7%高于对照组60.0%，且实验组临床出血量少于对照组，存在差异（P<0.05）。结论：临床针对早孕及早期中孕引产产妇行米非司酮、米索前列醇联合效果作用显著，可提高临床流产成功率，减少产后出血量，值得学习。
Objective: To study the clinical effects of combination therapy of mifepristone and misoprostol in early pregnancy and early pregnancy. Methods: From March 2011 to May 2015 in our hospital, pregnant women receiving early pregnancy and early pregnancy induced 120 cases as the survey, divided into different treatment groups, including: control group of pregnant women underwent conventional aspiration therapy The experimental group of pregnant women with mifepristone and misoprostol combination therapy, the clinical prognosis evaluation. Results: The results of clinical abortion in experimental group were 81.7% higher than 60.0% in control group, and the clinical bleeding volume in experimental group was less than that in control group (P <0.05). Conclusions: The clinical effect of mifepristone and misoprostol on pregnant women in early pregnancy and early pregnancy is significant, which can improve the success rate of clinical abortion, reduce the amount of postpartum hemorrhage, and is worth learning.